Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2010 1
2011 2
2012 3
2013 4
2014 5
2015 10
2017 6
2018 5
2019 14
2020 17
2021 22
2022 22
2023 15
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean cheng cheng fu (29 results)?
Comparison of valganciclovir versus foscarnet for the treatment of cytomegalovirus viremia in adult acute leukemia patients after allogeneic hematopoietic cell transplantation.
Zhu J, Xu M, Ru Y, Gong H, Ding Y, Zhu Z, Xu Y, Fan Y, Zhang X, Tu Y, Sun A, Qiu H, Jin Z, Tang X, Han Y, Fu C, Chen S, Ma X, Chen F, Song T, Wu D, Chen J. Zhu J, et al. Among authors: fu c. Leuk Lymphoma. 2024 Mar 12:1-9. doi: 10.1080/10428194.2024.2321322. Online ahead of print. Leuk Lymphoma. 2024. PMID: 38475670
Influence of the Omicron outbreak on allo-HSCT recipients in China: a single-center short-term observational cohort study.
Zhang Z, Qiao M, Bao X, Lu J, Zhang J, Dou X, He X, Wu X, Fu C, Tang X, Miao M, Han Y, Xue S, Qiu H, Li C, Wang Y, Jin Z, Wu D, Chen SN. Zhang Z, et al. Among authors: fu c. Bone Marrow Transplant. 2024 Mar;59(3):437-439. doi: 10.1038/s41409-023-02188-w. Epub 2024 Jan 11. Bone Marrow Transplant. 2024. PMID: 38212670 No abstract available.
Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial.
Xia Z, Leng Y, Fang B, Liang Y, Li W, Fu C, Yang L, Ke X, Jiang H, Weng J, Liu L, Zhao Y, Zhang X, Huang Z, Liu A, Shi Q, Gao Y, Chen X, Pan L, Cai Z, Wang Z, Wang Y, Fan Y, Hou M, Ma Y, Hu J, Liu J, Zhou J, Zhang X, Meng H, Lu X, Li F, Ren H, Huang B, Shao Z, Zhou H, Hu Y, Yang S, Zheng X, Wei P, Pang H, Yu W, Liu Y, Gao S, Yan L, Ma Y, Jing H, Du J, Ling W, Zhang J, Sui W, Wang F, Li X, Chen W. Xia Z, et al. Among authors: fu c. BMC Cancer. 2023 Oct 14;23(1):980. doi: 10.1186/s12885-023-11489-8. BMC Cancer. 2023. PMID: 37838670 Free PMC article. Clinical Trial.
113 results